Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil add-on to sitagliptin and metformin in type 2 diabetes
IRCT20180417039339N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Verapamil add-on with Placebo add-on (2 arms). Primary endpoint: Frequency of expression of GLP-1R mRNA. Started Aug 2018; status: completed.
02
Drugs
verapamil
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20180417039339N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180417039339N1.